tiprankstipranks
Treatment.Com International, Inc. (TSE:TRUE)
:TRUE
Canadian Market

Treatment.com International (TRUE) Dividend Date & History

Compare
5 Followers
Treatment.com International (TSE:TRUE) has no upcoming dividends

Other Large Cap Stocks Paying Dividends

Name
Dividend Yield
Smart Score
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Follow
$4.037 (6.92%)
$97.70B
8.84
38.02%
3 Buy
3 Hold
1 Sell
Moderate Buy
$1.108 (4.09%)
$194.67B
18.18
57.67%
17 Buy
4 Hold
0 Sell
Strong Buy
$0.875 (15.72%)
$796.79M
-0.59
-61.92%
0 Buy
1 Hold
1 Sell
Moderate Sell
$6.676 (2.55%)
$242.52B
40.69
33.47%
7 Buy
6 Hold
1 Sell
Moderate Buy
$6.6 (4.22%)
$275.25B
16.08
4.31%
12 Buy
3 Hold
0 Sell
Strong Buy
$3.77 (2.96%)
$69.38B
11.13
5.51%
14 Buy
9 Hold
0 Sell
Moderate Buy
$1.282 (7.36%)
$59.91B
13.60
16.17%
9 Buy
1 Hold
0 Sell
Strong Buy
$2.703 (6.71%)
$9.20B
16.09
15.10%
2 Buy
1 Hold
0 Sell
Moderate Buy
$1.916 (8.34%)
$15.45B
9.43
12.19%
7 Buy
1 Hold
0 Sell
Strong Buy

FAQ

Does Treatment.Com International, Inc. pay dividends?
No, Treatment.com International (TSE:TRUE) has not paid a dividend within the past 12 months.
    How much is Treatment.Com International, Inc.'s dividend?
    Treatment.Com International, Inc. (TSE:TRUE) does not pay a dividend
    When is Treatment.Com International, Inc. ex-dividend date?
    Treatment.Com International, Inc. (TSE:TRUE) does not pay a dividend.
    When is Treatment.Com International, Inc. dividend payment date?
    Treatment.Com International, Inc. (TSE:TRUE) does not pay a dividend.
    Does Treatment.Com International, Inc. have sufficient earnings to cover their dividend?
    The Treatment.Com International, Inc. has paid a dividend in the last year and may provide dividends in the near future.
    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis